arrow
G

Gérard Zurawski

vaccine research institute (vri)
H指数:61
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)
2024-11-010
OAAI
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
2022-07-089
OA
Design, immunogenicity, and efficacy of a pan- sarbecovirus dendritic-cell targeting vaccine
2022-06-0117
OAAI
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
2021-09-0125
OAAI
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice
2020-11-3025
OAAI
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
2017-12-0192
OAAI
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses
2017-05-0132
OAAI
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells

CD40和树突状细胞表面凝集素对CD8和CD4 T细胞的外源抗原呈递的功能特性

2016-03-0162
OAAI